Patent · US Active

Methods for increasing efficacy of FOLR1 cancer therapy

US8709432B2 · kind B2 · utility

21Cited by
9References
45Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 30, 2012
Grant dateApr 29, 2014
Priority date
Expiry dateMar 30, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods to improve the success of cancer therapies that target the human folate receptor 1 are provided. Kits comprising reagent useful in the methods are further provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.